Bergenbio Asa Stock Short Ratio
| BGBIO Stock | NOK 10.87 0.48 4.23% |
Bergenbio ASA fundamentals help investors to digest information that contributes to Bergenbio ASA's financial success or failures. It also enables traders to predict the movement of Bergenbio Stock. The fundamental analysis module provides a way to measure Bergenbio ASA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bergenbio ASA stock.
Bergenbio |
Bergenbio ASA Company Short Ratio Analysis
Bergenbio ASA's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Bergenbio ASA has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The short ratio for all Norway stocks is 100.0% higher than that of the company.
Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Bergenbio Fundamentals
| Return On Equity | -0.96 | |||
| Return On Asset | -0.49 | |||
| Operating Margin | (383.14) % | |||
| Current Valuation | 421.26 M | |||
| Shares Outstanding | 88.66 M | |||
| Shares Owned By Insiders | 34.95 % | |||
| Shares Owned By Institutions | 19.17 % | |||
| Price To Book | 3.92 X | |||
| Price To Sales | 756.59 X | |||
| Revenue | 774 K | |||
| Gross Profit | 774 K | |||
| EBITDA | (308 M) | |||
| Net Income | (309.36 M) | |||
| Cash And Equivalents | 436.65 M | |||
| Cash Per Share | 5.59 X | |||
| Total Debt | 942 K | |||
| Debt To Equity | 0.10 % | |||
| Current Ratio | 8.23 X | |||
| Book Value Per Share | 1.86 X | |||
| Cash Flow From Operations | (303.34 M) | |||
| Earnings Per Share | (3.50) X | |||
| Target Price | 20.25 | |||
| Number Of Employees | 34 | |||
| Beta | 1.63 | |||
| Market Capitalization | 609.1 M | |||
| Total Asset | 450.24 M | |||
| Net Asset | 450.24 M |
About Bergenbio ASA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bergenbio ASA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bergenbio ASA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bergenbio ASA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Bergenbio Stock
Bergenbio ASA financial ratios help investors to determine whether Bergenbio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bergenbio with respect to the benefits of owning Bergenbio ASA security.